In our study, we show, for the first time, that TGFβ signaling inhibits IRS-1 expression and activation in colon cancer cells in vitro and in vivo and that upregulated IRS-1 contributes to attenuation of TGFβ signaling-mediated tumor suppressive phenotypes. Here, IRS1 is linked to neoplasm.